Revenue, Deferred Revenue, and Deferred Device and Contract Costs (Tables)

9 Months Ended

Sep. 30, 2026

Revenue from Contract with Customer [Abstract]

The following table presents the Company’s revenues disaggregated by revenue source and geography (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Revenue by Type
Access Fees	$	466,721	$	520,907	$	1,425,591	$	1,570,346
Other	138,381		105,532		400,283		317,362
Total Revenue	$	605,102	$	626,439	$	1,825,874	$	1,887,708

Revenue by Geography
U.S.	$	489,214	$	509,774	$	1,468,079	$	1,554,433
International	115,888		116,665		357,795		333,275
Total Revenue	$	605,102	$	626,439	$	1,825,874	$	1,887,708

Schedule of Deferred Revenue Activities

The following table summarizes deferred revenue activities for the periods presented (in thousands):


	Nine Months Ended September 30,
	2026		2025
Beginning balance	$	71,444	$	89,082
Balances assumed as part of business acquisitions	—		890
Cash collected	52,825		65,752
Revenue recognized	(53,135)		(74,374)
Ending balance	$	71,134	$	81,350

Schedule of Deferred Device and Contract Costs

Deferred device and contract costs are classified as a component of prepaid expenses and other current assets or other assets, depending on term, and consisted of the following (in thousands):


	As of
	September 30,		December 31,
	2026		2025
Deferred device and contract costs, current	$	36,615	$	31,820
Deferred device and contract costs, non-current	14,789		14,129
Total deferred device and contract costs	$	51,404	$	45,949

Deferred device and contract costs were as follows (in thousands):


	Deferred Device and Contract Costs
Beginning balance as of December 31, 2025	$	45,949
Additions	43,034
Cost of revenue recognized	(37,579)
Ending balance as of September 30, 2026	$	51,404